ChromaDex Corporation Stock News

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #financialresults--ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs. May 12, 2022 at 4:30 p.m. ET to discuss its financial re

ChromaDex (CDXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ChromaDex (CDXC) said it was granted another U.S. Patent providing additional intellectual property protection for its Niagen ingredient and other nicotinamide adenine dinucleotide…

ChromaDex <> stock has fallen following its Q4 results.Q4 total net sales rose +14.98% to $17.76M Y/Y but missed estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 27.27% and 3.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ChromaDex Corporation (CDXC) CEO Rob Fried on Q4 2021 Results - Earnings Call Transcript

ChromaDex press release (CDXC): Q4 GAAP EPS of -$0.08 beats by $0.02.Revenue of $17.8M (+15.6% Y/Y) misses by $0.97M.2022 OutlookLooking forward, for the full year, the Company…

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #earnings--ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2021 financial results. Fourth Quarter 2021 and Recent Highlights Total net sales were $17.8 million, up 15% year over year. Tru Niagen® net sales were $14.1 million, a 14% increase year over year. Gross margin was 61.2%, up 20 basis points year over year. Net loss was $5.3 million or $0.08 loss per share, an improvement of $0.02 per share year over year. In January 2022, announced a suppl

ChromaDex (CDXC) delivered earnings and revenue surprises of 27.27% and 3.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ChromaDex (NASDAQ:CDXC) is scheduled to announce Q4 earnings results on Wednesday, March 9th, after market close.The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate…

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth quarter, compared to

Aeglea (AGLE) delivered earnings and revenue surprises of 3.12% and 18.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?